Abstract:Background Depression is the most widely acknowledged psychological problem among end-stage renal disease (ESRD) patients. Depression may be associated with VD deficiency. The aims of this study are to (a) elucidate the prospective association between HsCRP, VD contents and depressive symptoms in the dialyzed population, and (b) find the effect of calcitriol supplementation on depression in dialyzed patients. Methods In this prospective study, 484 dialysis patients (382 hemodialysis [HD] cases and 102 peritoneal dialysis [PD] cases; aged 18–60 years) from two hospitals in southeast China were included. The depression in these patients was evaluated using the Chinese version of Beck’s Depression Inventory (BDI). All subjects answered the BDI-I questionnaire for assessment of depression levels in summer. A cut-off value of 16 was set to include dialysis patients with depression. All patients were divided into two groups depending on the absence (Group1) or presence (Group 2) of depression. The two groups took 0.5 μg/day 1,25-Dihydroxyvitamin D orally for one year. BDI Scores were recalculated for all patients. Sociodemographic, clinical data, and serum VD contents were also collected. Results A total of 484 participants (247 men [51.0%] and 237 women [49.0%]) were surveyed. Depressive symptoms were found in 213 (44.0%) patients. The baseline serum VD level (VD2 + VD3) was 17.6 ± 7.7 nmol/L. Patients with depressive symptoms have significantly higher serum HsCRP level and significantly lower serum VD level compared with the control group. After one-year follow-up, the supplementation of 0.5 μg/day calcitriol slightly improved the microinflammatory state such as lowering mean serum HsCRP level and improving serum VD level, but not in significantly enhancing the depressive symptoms. Conclusions Calcitriol supplementation did not significantly enhance the depressive symptoms in our dialyzed population although patients with low levels of serum VD were more depressed. Therefore, more prospective randomized controlled trials are necessary to reveal the exact cause-and-effect relationship between VD status and depressive symptoms or VD status related to some specific subtypes in dialyzed patients.

Gender Difference in Vitamin A Levels in First-Episode Drug-Naïve Depression Patients: a Case-Control and 24-Weeks Follow-Up Study.

Sex Difference in Lipid Levels in First-Diagnosed Drug-Naïve Depression Patients: A Case-Control and 12-Weeks Follow-Up Study

The Relationship Between Vitamin D Levels in Seasonal Variations and Chinese Patients with First-Episode Drug-Naive Depression

Association Between Serum Vitamin Levels and Depression in U.S. Adults 20 Years or Older Based on National Health and Nutrition Examination Survey 2005–2006

Sex Differences in the Cognitive Function of First-Diagnosed, Drug-Naïve Depressed Patients: an Observational Case-Control Study.

Analyses of vitamin D2/D3 levels in moderately and severely depressive patients

Comparison of Hair Thyroid Hormones Between First‐episode and Recurrent Patients with Depression in Female Chinese

Vitamin D status in chronic dialysis patients with depression: a prospective study

Sex differences in erythrocyte fatty acid composition of first-diagnosed, drug-naïve patients with major depressive disorders

The reduction of vitamin D in females with major depressive disorder is associated with worse cognition mediated by abnormal brain functional connectivity

The Relationship Between Vitamin D, Clinical Manifestations, and Functional Network Connectivity in Female Patients With Major Depressive Disorder

Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency

Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials

Serum uric acid a depression biomarker.

Brain function mediates the association between low vitamin D and neurocognitive status in female patients with major depressive disorder

The effect of vitamin D supplementation on primary depression: A meta-analysis

Gender differences in the influence of escitalopram on prolac-tin levels in patients with first-episode depression

Analysis of Hair Cortisol Level in First-Episodic and Recurrent Female Patients with Depression Compared to Healthy Controls.

Vitamin D Supplementation for the Treatment of Depressive Symptoms in Women with Type 2 Diabetes: A Randomized Clinical Trial

Dietary Zinc Intake Affects the Association Between Dietary Vitamin A and Depression: A Cross-Sectional Study

Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder